These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10595639)

  • 1. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
    Gilmore G; Thom J; Baker RI
    Thromb Haemost; 1996 Feb; 75(2):372-3. PubMed ID: 8815593
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
    Burgess JK; Chong BH
    Eur J Haematol; 1997 Apr; 58(4):279-85. PubMed ID: 9186540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
    Wun TC
    Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glycosaminoglycans with acetaldehyde on the activation of prothrombin.
    Brecher AS; Adamu MT
    Can J Physiol Pharmacol; 2005 May; 83(5):431-8. PubMed ID: 15897925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
    Ishida M; Nakada Y; Horiuchi M; Sakamoto F
    Arzneimittelforschung; 1998 Aug; 48(8):818-21. PubMed ID: 9748709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.
    Brecher AS; Adamu MT
    Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous formation of factor Xa and IIa and on thrombelastometry profiles in cord versus adult blood.
    Cvirn G; Hoerl G; Tafeit E; Heinl N; Wodrig K; Wagner T; Koestenberger M; Juergens G
    Neonatology; 2011; 100(1):23-31. PubMed ID: 21150227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.
    Castro-López V; Harris LF; O'Donnell JS; Killard AJ
    Anal Bioanal Chem; 2011 Jan; 399(2):691-700. PubMed ID: 20972772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
    Takahashi H; Ebihara S; Okazaki T; Asada M; Sasaki H; Yamaya M
    Br J Pharmacol; 2005 Oct; 146(3):333-43. PubMed ID: 16041398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
    Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY; Ji SL; Song HF; Ye QN; Cao JC
    Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.